Russell Investments Group Ltd. Has $730,000 Stock Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Russell Investments Group Ltd. grew its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 21.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 18,421 shares of the company’s stock after purchasing an additional 3,248 shares during the period. Russell Investments Group Ltd.’s holdings in Acadia Healthcare were worth $730,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Tidal Investments LLC boosted its holdings in Acadia Healthcare by 7.9% in the third quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock worth $296,000 after acquiring an additional 340 shares in the last quarter. Franklin Resources Inc. lifted its holdings in shares of Acadia Healthcare by 273.1% in the 3rd quarter. Franklin Resources Inc. now owns 105,228 shares of the company’s stock worth $6,673,000 after purchasing an additional 77,027 shares in the last quarter. Oddo BHF Asset Management Sas acquired a new stake in Acadia Healthcare in the 3rd quarter valued at $1,613,000. Principal Financial Group Inc. increased its stake in Acadia Healthcare by 2.1% during the 3rd quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock valued at $41,653,000 after purchasing an additional 13,368 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in Acadia Healthcare by 17.0% during the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after buying an additional 454,044 shares during the last quarter.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. TD Cowen decreased their price objective on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a report on Tuesday, January 7th. Royal Bank of Canada dropped their target price on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a report on Monday, March 3rd. Mizuho decreased their price target on Acadia Healthcare from $48.00 to $37.00 and set a “neutral” rating for the company in a report on Tuesday, March 25th. Finally, Bank of America dropped their price objective on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a research note on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $50.39.

Acadia Healthcare Trading Down 4.1 %

Shares of Acadia Healthcare stock opened at $20.60 on Wednesday. The stock has a fifty day moving average price of $30.57 and a 200-day moving average price of $39.30. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The firm has a market cap of $1.90 billion, a PE ratio of 6.75, a P/E/G ratio of 1.46 and a beta of 1.13. Acadia Healthcare Company, Inc. has a 1 year low of $20.36 and a 1 year high of $82.41.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.